REGEN BIOPHARMA, INC. (RGBPP) Shareholders’ equity 2017–2025
REGEN BIOPHARMA, INC. (RGBPP) shareholders’ equity at each fiscal year-end, per SEC filings.
-$6.3MFY2025 · since FY2017: -$5.3M → -$6.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.3M | -20.4% |
| FY2024 | -$5.2M | -2.2% |
| FY2023 | -$5.1M | +36.5% |
| FY2022 | -$8.0M | +40.4% |
| FY2021 | -$13.5M | -83.9% |
| FY2020 | -$7.3M | +32.8% |
| FY2019 | -$10.9M | -19.6% |
| FY2018 | -$9.1M | -73.7% |
| FY2017 | -$5.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice